HEADER MEMBRANE PROTEIN 24-FEB-12 4AKM TITLE CRYSTAL STRUCTURE OF THE HUMAN LYSOSOME-ASSOCIATED MEMBRANE PROTEIN TITLE 2 LAMP-3 (AKA DC-LAMP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN 3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MEMBRANE-PROXIMAL PART OF LUMINAL DOMAIN, RESIDUES 222-381; COMPND 5 SYNONYM: LAMP-3, LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 3, DC- COMPND 6 LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN, DC LAMP, PROTEIN TSC403, COMPND 7 CD_ANTIGEN=CD208; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO LEC3.2.8.1 KEYWDS MEMBRANE PROTEIN, GLYCOSYLATION, BETA PRISM EXPDTA X-RAY DIFFRACTION AUTHOR J.KRAUSZE,S.WILKE,K.BUESSOW REVDAT 5 09-OCT-24 4AKM 1 HETSYN REVDAT 4 29-JUL-20 4AKM 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 17-JUL-19 4AKM 1 REMARK LINK REVDAT 2 12-JUL-17 4AKM 1 REVDAT 1 15-AUG-12 4AKM 0 JRNL AUTH S.WILKE,J.KRAUSZE,K.BUSSOW JRNL TITL CRYSTAL STRUCTURE OF THE CONSERVED DOMAIN OF THE DC JRNL TITL 2 LYSOSOMAL ASSOCIATED MEMBRANE PROTEIN: IMPLICATIONS FOR THE JRNL TITL 3 LYSOSOMAL GLYCOCALYX. JRNL REF BMC BIOL. V. 10 62 2012 JRNL REFN ESSN 1741-7007 JRNL PMID 22809326 JRNL DOI 10.1186/1741-7007-10-62 REMARK 2 REMARK 2 RESOLUTION. 2.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 3 NUMBER OF REFLECTIONS : 11232 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 562 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.2959 - 4.2544 1.00 2919 154 0.1895 0.1783 REMARK 3 2 4.2544 - 3.3828 0.69 1988 105 0.2186 0.2784 REMARK 3 3 3.3828 - 2.9569 1.00 2878 152 0.2760 0.3530 REMARK 3 4 2.9569 - 2.6873 0.99 2885 151 0.3261 0.3637 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.30 REMARK 3 SHRINKAGE RADIUS : 1.11 REMARK 3 K_SOL : 0.24 REMARK 3 B_SOL : 10.24 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.870 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.060 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.41770 REMARK 3 B22 (A**2) : 6.41770 REMARK 3 B33 (A**2) : -12.83540 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2516 REMARK 3 ANGLE : 1.023 3394 REMARK 3 CHIRALITY : 0.073 386 REMARK 3 PLANARITY : 0.003 442 REMARK 3 DIHEDRAL : 26.206 1528 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4AKM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1290051448. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAY-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X12 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.10371, 1.1042, 1.1009 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11238 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 200 DATA REDUNDANCY : 2.860 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.4800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.84 REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.470 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 5% PEG REMARK 280 6000, 0.1 M CITRIC ACID, PH 5.0; THEN SOAKED IN 0.014 M AMMONIUM REMARK 280 HEXACHLOROIRIDATE(III)HYDRATE AND CRYO-PROTECTED IN 30% PEG 6000. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.32667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 94.65333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 222 REMARK 465 SER A 378 REMARK 465 ASP A 379 REMARK 465 TYR A 380 REMARK 465 THR A 381 REMARK 465 HIS A 382 REMARK 465 HIS A 383 REMARK 465 HIS A 384 REMARK 465 HIS A 385 REMARK 465 HIS A 386 REMARK 465 HIS A 387 REMARK 465 ASP B 379 REMARK 465 TYR B 380 REMARK 465 THR B 381 REMARK 465 HIS B 382 REMARK 465 HIS B 383 REMARK 465 HIS B 384 REMARK 465 HIS B 385 REMARK 465 HIS B 386 REMARK 465 HIS B 387 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB CYS B 237 SG CYS B 274 1.87 REMARK 500 CB CYS A 237 SG CYS A 274 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 234 -30.05 -145.37 REMARK 500 MET A 242 164.11 178.13 REMARK 500 GLU A 298 110.10 64.72 REMARK 500 SER A 300 146.63 89.14 REMARK 500 PRO A 315 -70.01 -51.96 REMARK 500 GLU A 316 59.80 170.36 REMARK 500 CYS A 339 90.32 -163.55 REMARK 500 SER A 348 -163.13 -121.28 REMARK 500 PHE A 363 -96.88 68.36 REMARK 500 ASN A 372 4.59 -66.52 REMARK 500 VAL A 373 156.89 63.63 REMARK 500 VAL B 223 71.46 55.16 REMARK 500 SER B 256 69.91 -163.93 REMARK 500 GLN B 286 98.84 -58.48 REMARK 500 GLU B 298 131.23 67.02 REMARK 500 GLU B 299 36.25 -92.03 REMARK 500 ASP B 314 77.08 53.39 REMARK 500 CYS B 339 98.42 -160.67 REMARK 500 PHE B 363 -50.25 83.84 REMARK 500 CYS B 376 -104.88 -87.56 REMARK 500 SER B 377 100.89 -172.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 N-ACETYL-D-GLUCOSAMINE (NAG): N-ACETYL-D-GLUCOSAMINE IS REMARK 600 COVALENTLY ATTACHED TO N291 DBREF 4AKM A 222 381 UNP Q9UQV4 LAMP3_HUMAN 222 381 DBREF 4AKM B 222 381 UNP Q9UQV4 LAMP3_HUMAN 222 381 SEQADV 4AKM HIS A 382 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS A 383 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS A 384 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS A 385 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS A 386 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS A 387 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM VAL A 318 UNP Q9UQV4 ILE 318 VARIANT SEQADV 4AKM HIS B 382 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS B 383 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS B 384 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS B 385 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS B 386 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM HIS B 387 UNP Q9UQV4 EXPRESSION TAG SEQADV 4AKM VAL B 318 UNP Q9UQV4 ILE 318 VARIANT SEQRES 1 A 166 SER VAL LYS THR GLY ILE TYR GLN VAL LEU ASN GLY SER SEQRES 2 A 166 ARG LEU CYS ILE LYS ALA GLU MET GLY ILE GLN LEU ILE SEQRES 3 A 166 VAL GLN ASP LYS GLU SER VAL PHE SER PRO ARG ARG TYR SEQRES 4 A 166 PHE ASN ILE ASP PRO ASN ALA THR GLN ALA SER GLY ASN SEQRES 5 A 166 CYS GLY THR ARG LYS SER ASN LEU LEU LEU ASN PHE GLN SEQRES 6 A 166 GLY GLY PHE VAL ASN LEU THR PHE THR LYS ASP GLU GLU SEQRES 7 A 166 SER TYR TYR ILE SER GLU VAL GLY ALA TYR LEU THR VAL SEQRES 8 A 166 SER ASP PRO GLU THR VAL TYR GLN GLY ILE LYS HIS ALA SEQRES 9 A 166 VAL VAL MET PHE GLN THR ALA VAL GLY HIS SER PHE LYS SEQRES 10 A 166 CYS VAL SER GLU GLN SER LEU GLN LEU SER ALA HIS LEU SEQRES 11 A 166 GLN VAL LYS THR THR ASP VAL GLN LEU GLN ALA PHE ASP SEQRES 12 A 166 PHE GLU ASP ASP HIS PHE GLY ASN VAL ASP GLU CYS SER SEQRES 13 A 166 SER ASP TYR THR HIS HIS HIS HIS HIS HIS SEQRES 1 B 166 SER VAL LYS THR GLY ILE TYR GLN VAL LEU ASN GLY SER SEQRES 2 B 166 ARG LEU CYS ILE LYS ALA GLU MET GLY ILE GLN LEU ILE SEQRES 3 B 166 VAL GLN ASP LYS GLU SER VAL PHE SER PRO ARG ARG TYR SEQRES 4 B 166 PHE ASN ILE ASP PRO ASN ALA THR GLN ALA SER GLY ASN SEQRES 5 B 166 CYS GLY THR ARG LYS SER ASN LEU LEU LEU ASN PHE GLN SEQRES 6 B 166 GLY GLY PHE VAL ASN LEU THR PHE THR LYS ASP GLU GLU SEQRES 7 B 166 SER TYR TYR ILE SER GLU VAL GLY ALA TYR LEU THR VAL SEQRES 8 B 166 SER ASP PRO GLU THR VAL TYR GLN GLY ILE LYS HIS ALA SEQRES 9 B 166 VAL VAL MET PHE GLN THR ALA VAL GLY HIS SER PHE LYS SEQRES 10 B 166 CYS VAL SER GLU GLN SER LEU GLN LEU SER ALA HIS LEU SEQRES 11 B 166 GLN VAL LYS THR THR ASP VAL GLN LEU GLN ALA PHE ASP SEQRES 12 B 166 PHE GLU ASP ASP HIS PHE GLY ASN VAL ASP GLU CYS SER SEQRES 13 B 166 SER ASP TYR THR HIS HIS HIS HIS HIS HIS MODRES 4AKM ASN A 291 ASN GLYCOSYLATION SITE MODRES 4AKM ASN B 291 ASN GLYCOSYLATION SITE HET IR3 A1378 1 HET NAG A1379 14 HET IR3 A1380 1 HET IR3 B1379 1 HET NAG B1380 14 HET IR3 B1381 1 HETNAM IR3 IRIDIUM (III) ION HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 IR3 4(IR 3+) FORMUL 4 NAG 2(C8 H15 N O6) FORMUL 9 HOH *10(H2 O) HELIX 1 1 ASP A 264 THR A 268 5 5 HELIX 2 2 ASP B 264 ASN B 266 5 3 SHEET 1 AA 2 GLY A 226 ASN A 232 0 SHEET 2 AA 2 ARG A 235 VAL A 248 -1 O ARG A 235 N ASN A 232 SHEET 1 AB 2 ARG A 259 ASN A 262 0 SHEET 2 AB 2 ARG A 235 VAL A 248 1 O LEU A 246 N PHE A 261 SHEET 1 AC 2 PHE A 337 CYS A 339 0 SHEET 2 AC 2 LEU A 351 ALA A 362 -1 O VAL A 358 N CYS A 339 SHEET 1 AD 2 GLN A 343 GLN A 346 0 SHEET 2 AD 2 LEU A 351 ALA A 362 1 O VAL A 353 N LEU A 345 SHEET 1 AE 5 GLN A 269 ASN A 273 0 SHEET 2 AE 5 LYS A 278 PHE A 285 -1 O ASN A 280 N ASN A 273 SHEET 3 AE 5 GLY A 288 LYS A 296 -1 O GLY A 288 N PHE A 285 SHEET 4 AE 5 TYR A 301 THR A 311 -1 O TYR A 302 N THR A 295 SHEET 5 AE 5 VAL A 318 LYS A 323 -1 O TYR A 319 N LEU A 310 SHEET 1 AF 5 GLN A 269 ASN A 273 0 SHEET 2 AF 5 LYS A 278 PHE A 285 -1 O ASN A 280 N ASN A 273 SHEET 3 AF 5 GLY A 288 LYS A 296 -1 O GLY A 288 N PHE A 285 SHEET 4 AF 5 TYR A 301 THR A 311 -1 O TYR A 302 N THR A 295 SHEET 5 AF 5 MET A 328 THR A 331 -1 O MET A 328 N ILE A 303 SHEET 1 AG 2 VAL A 318 LYS A 323 0 SHEET 2 AG 2 TYR A 301 THR A 311 -1 O VAL A 306 N LYS A 323 SHEET 1 BA 2 GLY B 226 ASN B 232 0 SHEET 2 BA 2 ARG B 235 GLN B 249 -1 O ARG B 235 N ASN B 232 SHEET 1 BB 2 ARG B 258 ASN B 262 0 SHEET 2 BB 2 ARG B 235 GLN B 249 1 O LEU B 246 N PHE B 261 SHEET 1 BC 2 GLN B 343 GLN B 346 0 SHEET 2 BC 2 LEU B 351 ALA B 362 1 O VAL B 353 N LEU B 345 SHEET 1 BD 4 VAL B 373 GLU B 375 0 SHEET 2 BD 4 SER B 336 CYS B 339 1 O SER B 336 N ASP B 374 SHEET 3 BD 4 LEU B 351 ALA B 362 -1 O VAL B 358 N CYS B 339 SHEET 4 BD 4 GLN B 343 GLN B 346 1 O GLN B 343 N THR B 355 SHEET 1 BE 5 VAL B 373 GLU B 375 0 SHEET 2 BE 5 SER B 336 CYS B 339 1 O SER B 336 N ASP B 374 SHEET 3 BE 5 LEU B 351 ALA B 362 -1 O VAL B 358 N CYS B 339 SHEET 4 BE 5 ARG B 235 GLN B 249 -1 O LYS B 239 N GLN B 361 SHEET 5 BE 5 ARG B 258 ASN B 262 1 O ARG B 259 N VAL B 248 SHEET 1 BF 5 THR B 268 SER B 271 0 SHEET 2 BF 5 LYS B 278 PHE B 285 -1 O LEU B 282 N SER B 271 SHEET 3 BF 5 GLY B 288 LYS B 296 -1 O GLY B 288 N PHE B 285 SHEET 4 BF 5 SER B 300 VAL B 312 -1 O TYR B 302 N THR B 295 SHEET 5 BF 5 THR B 317 LYS B 323 -1 O THR B 317 N VAL B 312 SHEET 1 BG 5 THR B 268 SER B 271 0 SHEET 2 BG 5 LYS B 278 PHE B 285 -1 O LEU B 282 N SER B 271 SHEET 3 BG 5 GLY B 288 LYS B 296 -1 O GLY B 288 N PHE B 285 SHEET 4 BG 5 SER B 300 VAL B 312 -1 O TYR B 302 N THR B 295 SHEET 5 BG 5 MET B 328 ALA B 332 -1 O MET B 328 N ILE B 303 SHEET 1 BH 2 THR B 317 LYS B 323 0 SHEET 2 BH 2 SER B 300 VAL B 312 -1 O VAL B 306 N LYS B 323 SSBOND 1 CYS A 237 CYS A 274 1555 1555 2.05 SSBOND 2 CYS A 339 CYS A 376 1555 1555 2.03 SSBOND 3 CYS B 237 CYS B 274 1555 1555 2.04 SSBOND 4 CYS B 339 CYS B 376 1555 1555 2.05 LINK ND2 ASN A 291 C1 NAG A1379 1555 1555 1.44 LINK ND2 ASN B 291 C1 NAG B1380 1555 1555 1.44 CISPEP 1 GLU A 298 GLU A 299 0 -5.82 CISPEP 2 ASP A 314 PRO A 315 0 1.51 CISPEP 3 SER B 222 VAL B 223 0 -0.12 CISPEP 4 GLU B 298 GLU B 299 0 -1.06 CISPEP 5 ASP B 314 PRO B 315 0 -10.86 CISPEP 6 SER B 377 SER B 378 0 -4.28 CRYST1 52.600 52.600 141.980 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019011 0.010976 0.000000 0.00000 SCALE2 0.000000 0.021952 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007043 0.00000 MTRIX1 1 0.929100 0.357590 0.094370 -11.62670 1 MTRIX2 1 0.355850 -0.933880 0.035260 17.47254 1 MTRIX3 1 0.100740 0.000820 -0.994910 153.64288 1